Drug Databases and Their Contributions to Drug Repurposing

Drug Databases and Their Contributions to Drug Repurposing Publisher Pubmed

Masoudisobhanzadeh Y¹ ; Omidi Y² ; Amanlou M³ ; Masoudinejad A¹

Show Affiliations

1. Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
2. Research Center for Pharmaceutical Nanotechnology and Department of Pharamaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
3. Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, 14176-53955, Iran

Source: Genomics Published:2020

Abstract

Drug repurposing is an interesting field in the drug discovery scope because of reducing time and cost. It is also considered as an appropriate method for finding medications for orphan and rare diseases. Hence, many researchers have proposed novel methods based on databases which contain different information. Thus, a suitable organization of data which facilitates the repurposing applications and provides a tool or a web service can be beneficial. In this review, we categorize drug databases and discuss their advantages and disadvantages. Surprisingly, to the best of our knowledge, the importance and potential of databases in drug repurposing are yet to be emphasized. Indeed, the available databases can be divided into several groups based on data content, and different classes can be applied to find a new application of the existing drugs. Furthermore, we propose some suggestions for making databases more effective and popular in this field. © 2019

2. Trader As a New Optimization Algorithm Predicts Drug-Target Interactions Efficiently, Scientific Reports (2019)

3. Genome-Wide Subtraction Analysis and Reverse Vaccinology to Detect Novel Drug Targets and Potential Vaccine Candidates Against Ehrlichia Chaffeensis, Applied Biochemistry and Biotechnology (2023)

4. Computational Prediction of Drug-Drug Interactions Based on Drugs Functional Similarities, Journal of Biomedical Informatics (2017)

Experts (# of related papers)

Massoud Amanlou (2)

Reza Safdari (1)

Style	Citing Format
MLA	Masoudisobhanzadeh Y, et al.. "Drug Databases and Their Contributions to Drug Repurposing." Genomics, vol. 112, no. 2, 2020, pp. 1087-1095.
APA	Masoudisobhanzadeh Y, Omidi Y, Amanlou M, Masoudinejad A (2020). Drug Databases and Their Contributions to Drug Repurposing. Genomics, 112(2), 1087-1095.
Chicago	Masoudisobhanzadeh Y, Omidi Y, Amanlou M, Masoudinejad A. "Drug Databases and Their Contributions to Drug Repurposing." Genomics 112, no. 2 (2020): 1087-1095.
Harvard	Masoudisobhanzadeh Y et al. (2020) 'Drug Databases and Their Contributions to Drug Repurposing', Genomics, 112(2), pp. 1087-1095.
Vancouver	Masoudisobhanzadeh Y, Omidi Y, Amanlou M, Masoudinejad A. Drug Databases and Their Contributions to Drug Repurposing. Genomics. 2020;112(2):1087-1095.
BibTex	@article{ author = {Masoudisobhanzadeh Y and Omidi Y and Amanlou M and Masoudinejad A}, title = {Drug Databases and Their Contributions to Drug Repurposing}, journal = {Genomics}, volume = {112}, number = {2}, pages = {1087-1095}, year = {2020} }
RIS	TY - JOUR AU - Masoudisobhanzadeh Y AU - Omidi Y AU - Amanlou M AU - Masoudinejad A TI - Drug Databases and Their Contributions to Drug Repurposing JO - Genomics VL - 112 IS - 2 SP - 1087 EP - 1095 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract